We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.9B
AUM Growth
-$755M
Cap. Flow
-$1.47B
Cap. Flow %
-12.34%
Top 10 Hldgs %
33.73%
Holding
1,207
New
25
Increased
513
Reduced
317
Closed
41

Top Buys

Rank Stock Value
1
WELL icon
Welltower
WELL
+$281M
2
DOC icon
Healthpeak Properties
DOC
+$233M
3
LSI
Life Storage, Inc.
LSI
+$141M
4
CONE
CyrusOne Inc Common Stock
CONE
+$139M
5
ESS icon
Essex Property Trust
ESS
+$99.1M

Top Sells

Rank Stock Value
1
BXP icon
Boston Properties
BXP
+$240M
2
HST icon
Host Hotels & Resorts
HST
+$190M
3
HR icon
Healthcare Realty
HR
+$160M
4
DLR icon
Digital Realty Trust
DLR
+$157M
5
CCI icon
Crown Castle
CCI
+$153M

Sector Composition

Rank Sector Weight
1 Real Estate 71.54%
2 Technology 3.97%
3 Industrials 3.48%
4 Financials 2.88%
5 Healthcare 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKBA icon
1101
Akebia Therapeutics
AKBA
$327M
$2K ﹤0.01%
261
– –
ASRT
1102
DELISTED
Assertio
ASRT
$2K ﹤0.01%
6
– –
CBUS icon
1103
Cibus
CBUS
$130M
$2K ﹤0.01%
3
– –
CIEN icon
1104
PUT
Ciena
CIEN
$55.3B
$2K ﹤0.01%
2,032
– –
CRBP icon
1105
Corbus Pharmaceuticals
CRBP
$170M
$2K ﹤0.01%
10
– –
FBRX icon
1106
Forte Biosciences
FBRX
$1.12B
– –
0
– –
GERN icon
1107
Geron
GERN
$911M
$2K ﹤0.01%
880
– –
IBRX icon
1108
ImmunityBio
IBRX
$7.44B
$2K ﹤0.01%
439
– –
MCRB icon
1109
Seres Therapeutics
MCRB
$48M
$2K ﹤0.01%
11
– –
SVRA icon
1110
Savara
SVRA
$1.13B
$2K ﹤0.01%
169
– –
VCYT icon
1111
Veracyte
VCYT
$4.52B
$2K ﹤0.01%
188
– –
MRNS
1112
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
56
– –
NSTG
1113
DELISTED
NanoString Technologies, Inc.
NSTG
$2K ﹤0.01%
140
– –
PRTK
1114
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2K ﹤0.01%
173
– –
CNCE
1115
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2K ﹤0.01%
126
– –
FPRX
1116
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2K ﹤0.01%
160
– –
PGNX
1117
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2K ﹤0.01%
388
– –
RARX
1118
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2K ﹤0.01%
125
– –
SNNA
1119
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$2K ﹤0.01%
113
– –
SGYP
1120
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2K ﹤0.01%
1,363
– –
CORI
1121
DELISTED
Corium International, Inc.
CORI
$2K ﹤0.01%
198
– –
PDLI
1122
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
853
– –
ARDX icon
1123
Ardelyx
ARDX
$1.24B
$1K ﹤0.01%
263
– –
AVDL
1124
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
227
– –
CLLS
1125
Cellectis
CLLS
$286M
$1K ﹤0.01%
49
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2018 Portfolio in Review

As of Q3 2018, Daiwa Securities Group held 1,207 positions worth $11.9B, down 5.9% from $12.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $1.47B in Q3 2018, closing 41 positions and reducing 317 holdings. Its most notable exit was SITE Centers, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 73% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Altaba Inc worth $4.33M.

  • Daiwa Securities Group's largest Q3 2018 buy was Altaba Inc: 63,550 shares worth $4.33M.
  • Daiwa Securities Group added most to Welltower in Q3 2018, an estimated $281M increase.
  • Daiwa Securities Group's biggest Q3 2018 reduction was Boston Properties, cutting an estimated $240M.
  • Daiwa Securities Group fully exited SITE Centers in Q3 2018, selling an estimated $128M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $11.9B portfolio in Q3 2018.
  • Daiwa Securities Group opened 25 new positions and closed 41 in Q3 2018.
  • Daiwa Securities Group's portfolio value fell 5.9% quarter-over-quarter to $11.9B.

Based on Daiwa Securities Group's 13F filing for Q3 2018, filed 1 Nov 2018.